Fjarde Ap-fonden’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-30	Closed	-$5K	–	502
2025 Q1	$5K	Sell	30 -9,800	-100%	-$1.64M	﹤0.01%	519
2024 Q4	$1.81M	Buy	9,830 +4,200	+75%	+$809K	0.02%	483
2024 Q3	$1.11M	Buy	+5,630	New	+$1.17M	0.01%	501
2024 Q1	$1.77M	Buy	6,530 +1,800	+38%	+$430K	0.02%	502
2023 Q4	$1.12M	Buy	4,730 +3,500	+285%	+$688K	0.01%	511
2023 Q3	$241K	Sell	1,230 -1,800	-59%	-$370K	﹤0.01%	532
2023 Q2	$637K	Sell	3,030 -1,000	-25%	-$199K	0.01%	522
2023 Q1	$813K	Sell	4,030 -2,600	-39%	-$589K	0.01%	511
2022 Q4	$1.44M	Sell	6,630 -6,700	-50%	-$1.46M	0.02%	491
2022 Q3	$2.85M	Hold	13,330	–	–	0.04%	456
2022 Q2	$2.85M	Sell	13,330 -5,900	-31%	-$1.44M	0.04%	456
2022 Q1	$5.46M	Sell	19,230 -100	-0.5%	-$30.8K	0.05%	368
2021 Q4	$7.28M	Buy	19,330 +3,530	+22%	+$1.37M	0.06%	307
2021 Q3	$6.52M	Sell	15,800 -1,500	-9%	-$623K	0.06%	328
2021 Q2	$6.4M	Buy	+17,300	New	+$5.78M	0.06%	343